Stockscreener 앱 받기
4.70
0.00%
0.00
시간 외 거래:
4.71
0.010
+0.21%
전일 마감가:
$4.70
열려 있는:
$4.7
하루 거래량:
2.76M
Relative Volume:
0.99
시가총액:
$528.66M
수익:
$1.89B
순이익/손실:
$-496.52M
주가수익비율:
-0.9874
EPS:
-4.7598
순현금흐름:
$1.40M
1주 성능:
-0.42%
1개월 성능:
+18.69%
6개월 성능:
+15.48%
1년 성능:
-42.54%
1일 변동 폭
$4.635
$4.815
1주일 범위
$4.37
$4.905
52주 변동 폭
$2.095
$12.06
Evolent Health Inc Stock (EVH) Company Profile
명칭
Evolent Health Inc
전화
571-389-6000
주소
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Compare EVH vs VEEV, BTSG, TEM, HQY, HNGE
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
4.70 | 528.66M | 1.89B | -496.52M | 1.40M | -4.7598 |
VEEV
Veeva Systems Inc
|
163.38 | 26.34B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
64.14 | 12.58B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
50.56 | 9.39B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
85.66 | 7.27B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
67.81 | 5.29B | 646.34M | -512.40M | 202.76M | -6.6871 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-25 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-11-13 | 개시 | BMO Capital Markets | Outperform |
| 2025-11-13 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2025-01-10 | 개시 | Needham | Buy |
| 2024-12-03 | 재확인 | BTIG Research | Buy |
| 2024-11-08 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2024-10-11 | 개시 | KeyBanc Capital Markets | Overweight |
| 2024-08-09 | 업그레이드 | Truist | Hold → Buy |
| 2024-04-22 | 개시 | Citigroup | Buy |
| 2024-03-01 | 개시 | Oppenheimer | Outperform |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2023-12-06 | 개시 | JMP Securities | Mkt Outperform |
| 2023-10-16 | 개시 | UBS | Buy |
| 2023-04-12 | 개시 | Stephens | Overweight |
| 2022-11-01 | 개시 | Truist | Hold |
| 2022-07-29 | 개시 | RBC Capital Mkts | Outperform |
| 2022-03-30 | 개시 | Guggenheim | Buy |
| 2021-11-18 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-04-29 | 재개 | JP Morgan | Neutral |
| 2021-01-07 | 개시 | BTIG Research | Buy |
| 2020-07-06 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-06-05 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-06-02 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2018-10-05 | 재개 | Leerink Partners | Outperform |
| 2018-06-04 | 개시 | Piper Jaffray | Overweight |
| 2018-04-24 | 재개 | JP Morgan | Neutral |
| 2017-09-20 | 개시 | KeyBanc Capital Mkts | Overweight |
| 2017-06-02 | 개시 | Robert W. Baird | Outperform |
| 2017-03-14 | 개시 | Oppenheimer | Outperform |
| 2017-01-13 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-10-28 | 재개 | JP Morgan | Overweight |
| 2016-08-05 | 재확인 | FBR Capital | Outperform |
| 2016-07-26 | 개시 | Jefferies | Buy |
| 2016-07-13 | 재확인 | FBR Capital | Outperform |
| 2016-03-29 | 개시 | FBR Capital | Outperform |
| 2016-01-06 | 개시 | Canaccord Genuity | Buy |
| 2015-06-30 | 개시 | Goldman | Buy |
| 2015-06-30 | 개시 | JP Morgan | Overweight |
| 2015-06-30 | 개시 | Leerink Partners | Outperform |
| 2015-06-30 | 개시 | Sun Trust Rbsn Humphrey | Buy |
모두보기
Evolent Health Inc 주식(EVH)의 최신 뉴스
Evolent Health Leads Healthcare Technology Sector Focus - Kalkine Media
Q1 2026 Earnings Season Results for Healthcare Technology for Providers StocksNews and Statistics - IndexBox
Q1 Earnings Outperformers: Evolent Health (NYSE:EVH) And The Rest Of The Healthcare Technology for Providers Stocks - Yahoo Finance
Truist Financial Maintains Evolent Health(EVH.US) With Buy Rating, Announces Target Price $7 - Moomoo
Director Toyin Ajayi granted 41,096 RSUs at Evolent Health (EVH) - Stock Titan
Evolent Health (EVH) director Russell Glass receives 41,096 restricted stock units - Stock Titan
Evolent Health (EVH) director receives 41,096 restricted stock units grant - Stock Titan
[Form 4] Evolent Health, Inc. Insider Trading Activity - Stock Titan
Evolent Health (EVH) director receives 41,096 restricted stock units in equity grant - Stock Titan
Evolent Health (EVH) director Kim Keck granted 41,096 restricted stock units - Stock Titan
Evolent Health (EVH) director receives 41,096 restricted stock units award - Stock Titan
Director at Evolent Health (EVH) receives 41,096-share RSU grant - Stock Titan
Equity grant lifts Evolent (NYSE: EVH) director Barbarosh holdings - Stock Titan
EVH Stock On Track To Open At Record Low – Here’s Why Keybanc Turned Cautious - Stocktwits
Evolent Health Inc stock (US30050B1017): valuation metrics in focus after recent share price recover - AD HOC NEWS
Evolent Health Shareholders Approve Proposals at 2026 Meeting - The Globe and Mail
Evolent Health (EVH) holders back board, auditor and pay plan at 2026 meeting - Stock Titan
Evolent To Release Fourth Quarter 2024 Financial Results on Thursday, February 20, 2025 - Quantisnow
3 Healthcare Stocks We Approach with Caution - Yahoo Finance
3 Reasons EVH is Risky and 1 Stock to Buy Instead - Yahoo Finance
Evolent Health(EVH) Stock Options Chain | Quotes & News - Moomoo
Evolent Health Q1 earnings call highlights - MSN
EVH Stock Price Prediction 2025-2026 | Evolent Health Inc Forecast - 24/7 Wall St.
Evolent Health : EVH - 24/7 Wall St.
Analysts’ Top Healthcare Picks: ProMIS Neurosciences (PMN), Evolent Health (EVH) - The Globe and Mail
WATER ISLAND CREDIT OPPORTUNITIES FUND's Evolent Health Inc(EVH) Holding History - GuruFocus
Evolent Health to Participate in Upcoming Conferences - GuruFocus
EVH Maintained by Citigroup -- Price Target Raised to $5.50 - GuruFocus
Citigroup Adjusts Price Target on Evolent Health to $5.50 From $4, Maintains Buy Rating - Moomoo
Citi Maintains Evolent Health(EVH.US) With Buy Rating, Raises Target Price to $5.5 - Moomoo
EVH Stock Price, Quote & Chart | EVOLENT HEALTH INCA (NYSE:EVH) - ChartMill
Earnings call transcript: Evolent Health Q1 2026 beats EPS, stock surges By Investing.com - Investing.com South Africa
Earnings call transcript: Evolent Health Q1 2026 beats EPS, stock surges - Investing.com UK
Evolent Health Price Target Raised to $6.00/Share From $4.00 by Canaccord Genuity - Moomoo
EVH Maintained by Canaccord Genuity -- Price Target Raised to $6 - GuruFocus
Evolent Health Is Maintained at Buy by Canaccord Genuity - Moomoo
CCORF Maintains Evolent Health(EVH.US) With Buy Rating, Raises Target Price to $6 - Moomoo
Canaccord raises Evolent Health stock price target on new wins By Investing.com - Investing.com South Africa
Canaccord raises Evolent Health stock price target on new wins - Investing.com
AI-focused health plan tools get new steward at Quest Analytics - Stock Titan
TD Cowen raises Evolent Health stock price target on recovery track - Investing.com UK
TD Cowen Maintains Evolent Health(EVH.US) With Buy Rating, Raises Target Price to $8 - Moomoo
TD Cowen raises Evolent Health stock price target on recovery track By Investing.com - Investing.com South Africa
Evolent Health Inc (EVH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.22%
0.92%
자본화:
|
볼륨(24시간):